medigraphic.com

2013, Number 2

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2013; 51 (2)

Inappropriate prescribing in older adults with chronic-degenerative disease

Luna-Medina MA, Peralta-Pedrero ML, Pineda-Aquino V, Durán-Fernández YC, Ávalos-Mejía AM, Aguirre-García MC

Language: Spanish
References: 25
Page: 142-149
PDF size: 185.58 Kb.


ABSTRACT

Background: potentially inappropriate prescribing (IP) includes the use of drugs that represent greater risk than benefi t to the patient, the STOPP-START instrument, allows its detection, the aim was to evaluate its utility.
Methods: a descriptive cross-sectional study was performed. Randomly selecting records of older adults with at least one chronic degenerative disease, as last query had more than two months and have completed their monthly meeting at least four citations in the last 6 months were analyzed.
Results: the fi les from 285 patients were reviewed, females were 60 %, and the mean age was 74 ± 6 years. A total of 1749 prescriptions included 126 different drugs. The prevalence of inappropriate prescribing was 55 % (95 % CI = 49-61) and 87 % polypharmacy (95 % CI = 83-91). The cardiovascular, endocrine and skeletal muscle system diseases had the highest number of prescriptions and inappropriate prescribing. It was detected the omission of one or more drugs listed in 72 % of 75 % specifi c clinical circumstances.
Conclusions: the STOPP-START instrument is useful for detecting inappropriate prescribing. Also, the omission of indicated preventive treatments required for older adults with chronic degenerative diseases.


REFERENCES

  1. Sánchez-García S, de la Fuente-Hernández J, Juárez-Cedillo T, Mendoza J, Reyes-Morales H, Solórzano-Santos F, et al. Oral health service utilization by elderly benefi ciaries of the Mexican Institute of Social Security in Mexico City. BMC Health Serv Res. 2007;21(7):211.

  2. Mendoza-Núñez VM, Martínez-Maldonado ML, Correa-Muñoz E. Implementation of an active aging model in Mexico for prevention and control of chronic diseases in the elderly. BMC Geriatrics. 2009;9:1-7. Texto libre en http://www.biomedcentral. com/1471-2318/9/40

  3. Pérez-Peña JL. La prescripción médica es un acto científi co, ético y legal. Rev Cubana Med Gen Integr. 2002;18(2):114-6. Texto libre en http://www.imbiomed. com.mx/1/1/articulos.php?method=showDetail&id_ revista=69&id_seccion=301&id_ejemplar=1430&id_ articulo=13957

  4. Organización Mundial para la Salud. Guía de la buena prescripción. Ginebra, Suiza: OMS; 2011 [Consultado en enero de 2011]. Texto libre en http://www. icf.uab.es/universidad/gbp/castella/gbp.pdf

  5. Hamilton HJ, Gallagher PF, O´Mahony D. Inappropriate prescribing and adverse drug events in older people. BMC Geriatr. 2009;9:1-5. Texto libre en http:// www.ncbi.nlm.nih.gov/pmc/articles/PMC2642820/

  6. Page RL 2nd, Linnebur SA, Bryant LL, Ruscin JM. Inappropriate prescribing in the hospitalized elderly patient: defi ning the problem, evaluation tools and possible solutions. Clin Interv Aging. 2010;5:75- 87. Texto libre en http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC2854054/

  7. Ferner RE, Aronson JK, Communicating information about drug safety. BMJ. 2006;333(7559):143-5. Texto libre en http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC1502200/

  8. Hajjar ER, Cafi ero AC, Hanlon JT, Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345-51.

  9. Gallagher P, O’Mahony D. STOPP (Screening tool of older persons’ potentially inappropriate prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing. 2008;37(6):673-9.

  10. Barry PJ, Gallagher P, Ryan C, O’Mahony D. START (screening tool to alert doctors to the right treatment) – an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Aging. 2007;36(6):632-8.

  11. O´Mahony D, Gallagher P, Ryan C, Hamilton H, Barry P, O´Connor M, et al. STOPP & START criteria: a new approach to detecting potentially inappropriate prescribing in old age. Eur Geriatr Med. 2010;1(1):45-51.

  12. Organización Mundial de la Salud. Hombres, envejecimiento y salud. Ginebra, Suiza: OMS; 2001. [Consultado en enero de 2011]. Texto libre en http:// www.conapam.go.cr/pdf/Hombresenvejecimientoysalud. pdf

  13. Gallagher PF, Barry PJ, Ryan C, Hartigan I, O´Mahony D. Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers’ Criteria. Age Ageing. 2008;37(1):96-101.

  14. Kaur S, Mitchell G, Vitetta L, Roberts MS. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging. 2009;26(12):1013-28.

  15. Straand J, Fetveit A, Rognstad S, Gjelstad S, Brekke M, Dalen I. A cluster-randomized educational intervention to reduce inappropriate prescription patterns for elderly patients in general practice – the prescription peer academic detailing (Rx-PAD) study. BMC Health Serv Res. 2006;6:1-10. Texto libre en http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC1525163/

  16. Raebel MA, Charles J, Dugan J, Carroll NM, Korner EJ, Brand DW, et al. Randomized trial to improve prescribing safety in ambulatory elderly patients. J Am Geriatr Soc. 2007;55(7):977-85.

  17. Bjerrum L, Sogaard J, Hallas J, Kragstrup J. Methods for estimating the occurrence of polypharmacy means of a prescription data. Eur J Clin Pharmacol. 1998;54(3):197-202.

  18. Dhall J, Larrat EP, Laplane KL. Use of potentially inappropriate drugs in nursing homes. Pharmacotherapy 2002;22(1):88-96.

  19. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287(3):337-44.

  20. Alvarado-Orozco M, Mendoza-Núñez VM. Prevalencia y factores de riesgo para polifarmacia en adultos mayores del Valle del Mezquital, Hidalgo. Rev Mex Cien Farm. 2006;37(4):12-20. Texto libre en http://redalyc.uaemex.mx/pdf/579/57937403.pdf

  21. Rollason V, Vogt N. Reduction of polypharmacy in the elderly. Drugs Aging. 2003;20(11):817-32.

  22. Lau DT, Kasper JD, Potter DE, Lyles A, Bennett RG. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med. 2005;165(1):68-74.

  23. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15-29. Texto libre en http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC443443/.

  24. Grymonpre R, Ogilvie R, Rochon P. Cardiovascular drug therapy improving benefi ts and reducing risks in the older adults. 2002. [Consultado en febrero de 2012]. Texto libre en http://www.ccs.ca/download/ consensus_conference/consensus_conference_archives/ 2002_08.pdf

  25. Department of Health. [Sitio web]. Benzodiazepines: good practice guidelines for clinicians. Leanai, Dublin: Department of Health and Children; 2002.




2020     |     www.medigraphic.com